David De-Keyzer

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Global access programs (GAPs) provide access to medicinal products for patients with serious medical conditions and no commercially available treatment options. Providing early access to medicines can be challenging for a pharmaceutical company. The demand for a GAP often occurs at a time when other activities are the prime focus, such as delivery of(More)
  • 1